In collaboration with University “Politehnica” Bucharest, Sara Pharm Solution scientists have implemented a knowledge-based, hydrogen bonding propensity model in order to quantify the hydrogen bonding strength between a cytostatic drug and inorganic or inorganic-organic drug delivery systems. Beside fundamental insight into the drug-counterion-carrier system, their efforts have yielded a new strategy for greatly improving the dissolution rate of poorly soluble drugs. More about this topic is available in the RSC Advances paper, found athttp://pubs.rsc.org/en/Content/ArticleLanding/2015/RA/c4ra11224e# .